Bailly C, Clery PF, Faivre-Chauvet A et al (2016) Immuno-PET for Clinical Theranostic Approaches. Int J Mol Sci 18(1):57

Article  PubMed  PubMed Central  Google Scholar 

Manafi-Farid R, Ataeinia B, Ranjbar S et al (2022) ImmunoPET: Antibody-based PET imaging in solid tumors. Front Med 9:916693

Article  Google Scholar 

Dewulf J, Adhikari K, Vangestel C, Wyngaert TVD, Elvas F (2020) Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders-An Update. Cancers 12(7):1868

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brown EL, Shmuel S, Mandleywala K et al (2023) Immuno-PET detects antibody-drug potency on coadministration with statins. J Nucl Med 64(10):1638–1646

Article  CAS  PubMed  PubMed Central  Google Scholar 

Massicano AVF, Lee S, Crenshaw BK et al (2019) Imaging of HER2 with [(89)Zr]pertuzumab in response to T-DM1 therapy. Cancer Biother Radiopharm 34(4):209–217

CAS  PubMed  PubMed Central  Google Scholar 

Mortimer JE, Bading JR, Frankel PH et al (2022) Use of (64)Cu-DOTA-trastuzumab PET to predict response and outcome of patients receiving trastuzumab emtansine for metastatic breast cancer: A pilot study. J Nucl Med 63(8):1145–1148

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lau J, Rousseau E, Kwon D, Lin KS, Benard F, Chen X (2020) Insight into the development of PET radiopharmaceuticals for oncology. Cancers 12(5):1312

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brasse D, Nonat A (2015) Radiometals: towards a new success story in nuclear imaging? Dalton Trans 44(11):4845–4858

Article  CAS  PubMed  Google Scholar 

Aluicio-Sarduy E, Ellison PA, Barnhart TE, Cai W, Nickles RJ, Engle JW (2018) PET radiometals for antibody labeling. J Labelled Comp Radiopharm 61(9):636–651

Article  CAS  PubMed  PubMed Central  Google Scholar 

Slamon DJ, Leyland-Jones B, Shak S et al (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344(11):783–792

Article  CAS  PubMed  Google Scholar 

Asif HM, Sultana S, Ahmed S, Akhtar N, Tariq M (2016) HER-2 positive breast cancer - a mini-review. Asian Pac J Cancer Prev 17(4):1609–1615

Article  PubMed  Google Scholar 

Ignatiadis M, Desmedt C, Sotiriou C, de Azambuja E, Piccart M (2009) HER-2 as a target for breast cancer therapy. Clin Cancer Res 15(6):1848–1852

Article  CAS  PubMed  Google Scholar 

Schulz R, Streller F, Scheel AH et al (2014) HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer. Cell Death Dis 5(1):e980

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oh DY, Bang YJ (2020) HER2-targeted therapies - a role beyond breast cancer. Nat Rev Clin Oncol 17(1):33–48

Article  CAS  PubMed  Google Scholar 

Ducharme M, Hall L, Eckenroad W et al (2023) Evaluation of [(89)Zr]Zr-DFO-2Rs15d nanobody for imaging of HER2-positive breast cancer. Mol Pharm 20(9):4629–4639

Article  CAS  PubMed  Google Scholar 

Ge S, Li J, Yu Y et al (2021) Review: Radionuclide molecular imaging targeting HER2 in breast cancer with a focus on molecular probes into clinical trials and small peptides. Molecules 26(21):6482

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang J, Xu B (2019) Targeted therapeutic options and future perspectives for HER2-positive breast cancer. Signal Transduct Target Ther 4(1):34

Article  PubMed  PubMed Central  Google Scholar 

Chang AJ, Desilva R, Jain S, Lears K, Rogers B, Lapi S (2012) 89Zr-radiolabeled trastuzumab imaging in orthotopic and metastatic breast tumors. Pharmaceuticals 5(1):79–93

Article  PubMed  PubMed Central  Google Scholar 

Brandt M, Cardinale J, Aulsebrook ML, Gasser G, Mindt TL (2018) An overview of PET radiochemistry, Part 2: Radiometals. J Nucl Med 59(10):1500–1506

Article  CAS  PubMed  Google Scholar 

Massicano AVF, Marquez-Nostra BV, Lapi SE (2018) Targeting HER2 in nuclear medicine for imaging and therapy. Mol Imaging 17:1536012117745386

Article  PubMed  PubMed Central  Google Scholar 

Gebhart G, Lamberts LE, Wimana Z et al (2016) Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial. Ann Oncol 27(4):619–624

Article  CAS  PubMed  Google Scholar 

Dijkers EC, Oude Munnink TH, Kosterink JG et al (2010) Biodistribution of 89Zr-trastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer. Clin Pharmacol Ther 87(5):586–592

Article  CAS  PubMed  Google Scholar 

Bensch F, Brouwers AH, Lub-de Hooge MN et al (2018) (89)Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up. Eur J Nucl Med Mol Imaging 45(13):2300–2306

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ulaner GA, Hyman DM, Lyashchenko SK, Lewis JS, Carrasquillo JA (2017) 89Zr-trastuzumab PET/CT for detection of human epidermal growth factor receptor 2-positive metastases in patients with human epidermal growth factor receptor 2-negative primary breast cancer. Clin Nucl Med 42(12):912–917

Article  PubMed  PubMed Central  Google Scholar 

Ulaner GA, Hyman DM, Ross DS et al (2016) Detection of HER2-positive metastases in patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT. J Nucl Med 57(10):1523–1528

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pyles JM, Massicano AVF, Appiah JP, Bartels JL, Alford A, Lapi SE (2021) Production of (52)Mn using a semi-automated module. Appl Radiat Isot 174:109741

Article  CAS  PubMed  Google Scholar 

Carter LM, Kesner AL, Pratt EC et al (2020) The Impact of Positron Range on PET Resolution, Evaluated with Phantoms and PHITS Monte Carlo Simulations for Conventional and Non-conventional Radionuclides. Mol Imaging Biol 22(1):73–84

Article  CAS  PubMed  PubMed Central  Google Scholar 

Le Loirec C, Champion C (2007) Track structure simulation for positron emitters of physical interest. Part II: The case of the radiometals. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment 582(2):654–664

Fonslet J, Tietze S, Jensen AI, Graves SA, Severin GW (2017) Optimized procedures for manganese-52: Production, separation and radiolabeling. Appl Radiat Isot 121:38–43

Article  CAS  PubMed  Google Scholar 

Li M, Wang S, Kong Q, et al (2023) Advances in macrocyclic chelators for positron emission tomography imaging. View 4(5)

Graves SA, Hernandez R, Fonslet J et al (2015) Novel Preparation Methods of (52)Mn for ImmunoPET Imaging. Bioconjug Chem 26(10):2118–2124

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferreira CA, Kang L, Li C et al (2021) ImmunoPET of the differential expression of CD146 in breast cancer. Am J Cancer Res 11(4):1586–1599

CAS